HTFL HTFL Accrued Clinical Trial Expenses Current
Accrued Clinical Trial Expenses Current at other companies
Other financials
Where this comes from
Reported directly by HTFL in its filing.
Tagged under the XBRL concept htfl:AccruedClinicalTrialExpensesCurrent.
The official record: HTFL’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about HTFL's accrued clinical trial expenses current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is HTFL's accrued clinical trial expenses current?
- HTFL (HTFL) reported accrued clinical trial expenses current of $1.12M in Q1 2026.
- What does accrued clinical trial expenses current mean?
- Represents the estimated costs incurred for clinical research activities that have not yet been invoiced or paid by the company. This metric is vital for R&D-intensive companies to track the true burn rate and financial commitment to ongoing trials. It provides a more accurate picture of current liabilities than cash outflows alone.